Transgenomic Inc.

Transgenomic, Inc. provides products for the purification and analysis of nucleic acids used in the life sciences industry for research primarily on molecular genetics and diagnostics. The company also provides genetic variation analytical services to the medical research, clinical, and pharmaceutical markets. Its principal product includes WAVE System, a bioinstrument, which has broad applicability to genetic variation detection in molecular genetic research and molecular diagnostics.
The company also offers bioconsumable products, which include SURVEYOR Nuclease and a range of high pressure liquid chromatography separation columns; and consumable products that can be used on multiple independent platforms. In addition, it provides molecular clinical reference laboratory services, which specializes in mitochondrial and molecular diagnostic testing, including genetic testing for oncology, hematology, and inherited disorders, as well as pharmacogenomics research services.
The company's customers include academic and medical institutions, as well as pharmaceutical, biotech, and commercial companies. It sells its products through direct sales and support staff in the United States, the United Kingdom, and western Europe; and through dealers and distributors.
The company was founded in 1997 and is based in Omaha, Nebraska.
Contact Details
Executives
CEOand President
Craig J. Tuttle
CFO, PAO, VP, Sec. and Treasurer
Debra A. Schneider